News & Events CTI Announces New Offices in US and Australia

CTI Announces New Offices in US and Australia

August 21, 2019

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces new offices in the US and Australia. The company is opening a new office location in the US in both Chicago, IL and Indianapolis, IN, in addition to moving the office in Sydney, Australia to a new location to accommodate the growing workforce.

 

"We are pleased to announce more growth in both the US and Australia," remarks Joe Schroeder, Senior Manager of Real Estate Services at CTI. "The expanded office in Sydney and the new offices in Chicago and Indianapolis will allow us to continue to grow our ability to respond to the needs of both our internal teams and our partners in the industry."

CTI, with an annual staff retention rate of 95%, has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 120 pharmaceutical, biotechnology, and medical device clients. The company recently announced additional expansions in TexasCalifornia, and North Carolina.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com

Subscribe to our mailing list

* indicates required